T
MBOT icon

Transce3nd’s Microbot Medical MBOT Stock Holding History

Transce3nd’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-330
Closed -$832 – 742
2025
Q2 		$832 Hold
330
– – ﹤0.01% 1019
2025
Q1 		$498 Hold
330
– – ﹤0.01% 1038
2024
Q4 		$370 Buy
+330
New +$323 ﹤0.01% 1345

Other funds holding MBOT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Transce3nd's MBOT Position: Q3 2025 in Review

Transce3nd sold out of Microbot Medical (MBOT) in Q3 2025, closing a stake of 330 shares — an estimated $832 sold.

Transce3nd first reported a position in MBOT in Q4 2024 and held it in 3 quarters. The position peaked at $832 in Q2 2025. 67 funds tracked by Wall St. Rank hold MBOT as of Q3 2025.

  • Transce3nd reported no remaining Microbot Medical position as of Q3 2025 after selling out during the quarter.
  • Transce3nd sold 330 Microbot Medical shares in Q3 2025, an estimated $832.
  • Transce3nd first reported a position in Microbot Medical in Q4 2024 and held it in 3 quarters.
  • Transce3nd's Microbot Medical position peaked at $832 in Q2 2025.
  • 67 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.